Villa at Borgess Place: Psychotropic Drug Violations - MI
The citation against Villa at Borgess Place, issued August 13, 2025, identified a deficiency under the category of Freedom from Abuse, Neglect, and Exploitation. The specific violation concerned the facility's failure to prevent unnecessary psychotropic drug use, including medications that can chemically limit what a resident is able to do, how they move, and how clearly they think.
It was one of 18 deficiencies cited during the same inspection.
Psychotropic medications, a broad class that includes antipsychotics, antidepressants, anti-anxiety drugs, and sedative hypnotics, are among the most consequential drugs administered in nursing home settings. When given without adequate clinical justification, they can leave residents sedated, confused, and less able to communicate or move independently. In elderly populations, the risks compound. Falls become more likely. The ability to advocate for oneself, to tell a nurse something hurts or something is wrong, can diminish or disappear.
The federal inspection system classifies deficiencies by how widespread the problem is and how seriously it harmed, or could have harmed, residents. This citation received a scope and severity rating of D, meaning the problem was isolated rather than widespread, and that while no actual harm was documented at the time inspectors visited, there was potential for more than minimal harm. That last phrase carries weight. It means inspectors concluded the situation was not merely a paperwork problem. It was a clinical one, with real residents at risk.
The facility reported it had corrected the deficiency as of September 9, 2025, roughly four weeks after the inspection.
What the inspection record does not contain is the name of any resident who received the medication in question, the specific drug or drugs involved, how long they had been prescribed, or what clinical documentation, if any, the facility offered to justify them. The public record is a finding and a correction date. The details of what happened to the person, or people, in those rooms are not there.
That gap is not unusual. Federal inspection summaries of this kind routinely describe what category of violation occurred and how serious it was without identifying who was affected or what the experience was like from the inside. For families trying to understand what went on, or for residents who may not have known what they were being given or why, the public record offers little.
What it does offer is a pattern. Villa at Borgess Place received 18 citations during this single complaint inspection. The psychotropic medication finding was one thread in a larger fabric of deficiencies identified across a facility that, on this particular visit, inspectors found falling short in nearly two dozen distinct ways.
Nursing homes have faced federal scrutiny over antipsychotic and psychotropic drug use for more than a decade. A federal initiative launched in 2012 specifically targeted the overuse of antipsychotics in long-term care settings, and national rates of antipsychotic prescribing in nursing homes did fall significantly in the years that followed. But advocates and researchers have raised concerns that as antipsychotic rates declined, some facilities shifted toward other psychotropic drug classes, including anti-anxiety medications and sedative hypnotics, that carry similar risks but attracted less regulatory attention.
The concern is not that these medications are never appropriate. For residents with genuine psychiatric diagnoses, or for those in documented distress that cannot be addressed through other means, psychotropic drugs can be clinically necessary and humane. The problem, as federal regulators have identified it, is when they are used without that justification. When a nursing home gives a resident a drug that dulls their alertness or limits their movement not because of a documented clinical need but because a sedated resident is easier to manage, that is the scenario the regulation is designed to prevent.
The regulation cited here, federal tag F0605, addresses exactly that. It requires facilities to ensure that residents are not given psychotropic drugs unless those drugs are necessary to treat a specific, documented condition, and that the drugs are not being used in ways that effectively restrain what a resident can do.
Whether that is what happened at Villa at Borgess Place in August 2025, the inspection record does not say in those terms. What it says is that inspectors found a deficiency. That the deficiency involved unnecessary psychotropic medications. That someone, at minimum one resident in an isolated instance, was affected or at risk of being affected. And that the potential for harm was real enough that inspectors recorded it.
The facility has since reported a correction. Correction dates in federal inspection records represent a facility's self-reported claim that the problem has been addressed. They are not independently verified at the moment they are submitted, though subsequent inspections can and do revisit prior deficiencies.
For residents living at Villa at Borgess Place, and for the families who placed them there, the August inspection offers a partial and incomplete picture. Eighteen deficiencies across a single visit suggests a facility under significant strain, or facing significant compliance challenges, on the day inspectors arrived. The psychotropic medication citation sits within that broader context, one finding among many, each one representing a place where care fell short of what was required.
The person, or people, who received those medications, who may have spent days or weeks or longer in a state of altered function because of drugs that inspectors later concluded were unnecessary, are not named in the public record. Their experience, what it felt like to be less alert than they might have been, less able to move or speak or push a call button, is not in the file.
What is in the file is a D. A scope and severity level. A correction date. And the quiet, bureaucratic notation that while no actual harm was documented, there was potential for more than minimal harm.
That is the distance between what federal inspection records capture and what actually happens to people inside nursing homes. The records mark the finding. They do not follow the resident home, or to the hospital, or to wherever the consequences of that medication went after the inspectors left.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Villa At Borgess Place from 2025-08-13 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: October 21, 2026 · Our methodology
Villa at Borgess Place in Kalamazoo, MI was cited for violations during a health inspection on August 13, 2025.
It was one of 18 deficiencies cited during the same inspection.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.